Plain-English translation of NCT05527210 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Schizophrenia research guide →This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing whether Prebiotin®, a prebiotic powder made from a type of plant fiber, can help people with schizophrenia by reducing inflammation in the body. The idea is that this powder feeds helpful bacteria in your gut, which then produce a chemical called butyrate that may reduce swelling and improve thinking and mood. Researchers want to see if the medication can help with cognitive performance, symptoms, and overall health over 12 weeks.
People with schizophrenia often have higher levels of inflammation in their bodies and brains, which may make symptoms worse and affect thinking abilities. This study exists to explore whether this medication — which works by changing the bacteria in your gut — could be a safe and natural way to reduce that inflammation and improve how people feel and function.
If you join this study, you will receive either the prebiotic powder or a placebo (inactive powder) that looks the same — neither you nor the researchers will know which one you have. For 12 weeks, you'll mix 4 grams of powder with water three times a day and drink it. The study will check your thinking, mood, and blood work at the beginning and end to see if the treatment made any difference.
AI-generated summary from trial data · Aug 3, 2026 · Not medical advice
United States